PRECISION PHARMACOTHERAPY IN TYPE 2 DIABETES MELLITUS: EVALUATING THE CARDIO-RENAL AND GLYCEMIC EFFICACY OF TARGET-SPECIFIC PATHWAY MODULATION. (2026). World Bulletin of Public Health, 56, 82-84. https://www.scholarexpress.net/index.php/wbph/article/view/5983